Defilade Capital Management »

STAAR Surgical Company shares owned by Defilade Capital Management

Quarter-by-quarter ownership of STAAR Surgical Company (STAA) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in STAAR Surgical Company

Tip: Access up to 7 years of quarterly data

All positions including STAAR Surgical Company held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in STAAR Surgical Company by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.2M 322k 28.69

More positions owned by Defilade Capital Management

Eli Lilly & Co. (LLY)
Pfizer (PFE)
Veeva Sys Cl A Com (VEEV)
BioMarin Pharmaceutical (BMRN)
Ptc Therapeutics I (PTCT)
Baxter International (BAX)
Insmed Com Par $.01 (INSM)
Zimmer Holdings (ZBH)
Insulet Corporation (PODD)
Thermo Fisher Scientific (TMO)
Abbott Laboratories (ABT)
Ascendis Pharma A/s Ord Shs (ASND)
Solventum Corp Com Shs (SOLV)
Medtronic SHS (MDT)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding STAAR Surgical Company

Broadwood Capital
BlackRock
Madison Avenue Partners
Yunqi Capital
Point72 Asset Management
Goldman Sachs Group
Vanguard Portfolio Management
State Street Corporation
Anatole Investment Management
Vanguard Capital Management
Morgan Stanley
Geode Capital Management
Two Seas Capital
Dimensional Fund Advisors
Luke P. La Valle, Jr.

View all funds holding STAAR Surgical Company